PROV. KODIAK ISLAND MEDICAL CENTER
1. Target Overview & Investment Thesis
PROV. KODIAK ISLAND MEDICAL CENTER is a 24-bed suburban community hospital in KODIAK ISLAND BOROUGH, AK with $59.6M in net patient revenue and a -0.6% operating margin. The hospital serves a payer mix of 39.2% Medicare, 25.1% Medicaid, and 35.7% commercial.
Thesis: Turnaround. Our ML models identify $4.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.6% to 6.7% (+736bps).
| Net Revenue HCRIS | $59.6M |
| Current EBITDA COMPUTED | $-378K |
| Operating Margin COMPUTED | -0.6% |
| Occupancy HCRIS | 23.9% |
| Revenue / Bed COMPUTED | $2.5M |
| Net-to-Gross HCRIS | 56.2% |
| Distress Probability ML | 60.5% |
2. Market Context & Competitive Position
AK has 24 Medicare-certified hospitals with a median operating margin of -2.1%. The target's margin of -0.6% places it above the state median. Among 11 size-comparable peers (12-48 beds), the median margin is -10.7%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (12-48), prioritizing same-state peers. 11 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| PROV. KODIAK ISLAND MEDICAL CE (Target) | AK | 24 | $59.6M | -0.6% |
| NORTON SOUND REGIONAL HOSPITAL | AK | 18 | $148.7M | -28.6% |
| BARTLETT REGIONAL HOSPITAL | AK | 45 | $125.3M | -0.8% |
| SOUTH PENINSULA HOSPITAL | AK | 21 | $112.1M | -3.4% |
| KETCHIKAN MEDICAL CENTER | AK | 25 | $92.4M | -13.1% |
| ALASKA SPECIALTY HOSPITAL LLC | AK | 26 | $38.7M | -29.0% |
| PETERSBURG MEDICAL CENTER | AK | 12 | $19.5M | -10.7% |
| CORDOVA COMMUNITY MEDICAL CENT | AK | 13 | $12.3M | -5.5% |
| YK DELTA REGIONAL HOSPITAL | AK | 34 | $nan | nan% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.3M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.2M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.2M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $725K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $38K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-378K |
| + RCM Uplift | +$4.4M |
| Pro Forma EBITDA | $4.0M |
| Current Margin | -0.6% |
| Pro Forma Margin | 6.7% |
| WC Released (1x) | $2.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-581K | $41.3M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-581K | $45.3M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-523K | $59.6M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-523K | $64.8M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-640K | $19.6M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-640K | $21.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (25.1%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| Medium | Low occupancy | At 23.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 60.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 11 hospitals with 12-48 beds
- Same-state prioritization (n=12)
- Comp margins: P25=-20.9% / P50=-10.7% / P75=-4.5%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.